News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Earlier this month, the FDA approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay. The agency approved the vaccine only for people 65 and older and those 12 and ...
Limiting access stops healthy adults and children living with elderly or immunocompromised family members from choosing to do ...
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data ...
The U.S. approved a new COVID-19 vaccine made by Moderna but with limits on who can use it — not a replacement for the ...
The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback